(Alliance News) - Stocks in London opened lower on Friday as investors continued to fret over prospects of a recession as central banks raise interest rates. Read More
(Alliance News) - Oxford BioMedica PLC on Friday said it has signed a new three year agreement with AstraZeneca PLC, which will facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine. Read More
(Alliance News) - Oxford Biomedica on Friday said that it has signed a new three-year agreement with AstraZeneca, which would facilitate potential future manufacturing opportunities for the FTSE 100-listed drugmaker's Covid-19 vaccine. Read More
(Alliance News) - Stock prices in London are seen opening lower on Friday following another sell-off on Wall Street fuelled by recession fears, while focus will be on a slew of manufacturing PMI readings later in the day. Read More
(Alliance News) - Oxford BioMedica PLC on Tuesday noted that the US Food & Drug Administration lifted the clinical hold on Homology Medicines Inc's pheNIX gene therapy trial. Read More
(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review. Read More
(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News: Read More
(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on the tech-heavy Nasdaq index. Read More
(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US earnings season. Read More
(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause. Read More